[ad_1]
A preliminary study will determine if the vaccine is effective in people ages 6 to 17, according to a report from the University of Oxford.
About 300 volunteers will participate in the study, and the first participants are expected to be vaccinated this month.
The two-dose vaccine from AstraZeneca and Oxford University is welcome because it is cheaper and easier to transport than some vaccines developed by other companies.
AstraZeneca aims to produce $ 3 billion this year. vaccine doses, which promise to accelerate production to more than 200 million per month in April. dose.
It is strictly prohibited to use the information published by DELFI on other websites, in the media or elsewhere, or to distribute our material in any way without consent, and if consent has been obtained, it is necessary to indicate DELFI as the source.
[ad_2]
